一名患有BRAF V600E肺腺癌且对维莫非尼有反应的患者。 - Suppr

Suppr

超能文献

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.

作者信息

Gautschi Oliver, Pauli Chantal, Strobel Klaus, Hirschmann Astrid, Printzen Gert, Aebi Stefan, Diebold Joachim

机构信息

Department of Medicine, Luzerner Kantonsspital, Luzern, Switzerland.

出版信息

J Thorac Oncol. 2012 Oct;7(10):e23-4. doi: 10.1097/JTO.0b013e3182629903.

DOI:10.1097/JTO.0b013e3182629903

PMID:22743296

Abstract

摘要

相似文献

A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.一名患有BRAF V600E肺腺癌且对维莫非尼有反应的患者。

J Thorac Oncol. 2012 Oct;7(10):e23-4. doi: 10.1097/JTO.0b013e3182629903.

Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene.一名携带BRAF癌基因V600E突变的非小细胞肺癌患者的长期生存情况

Clin Lung Cancer. 2016 Mar;17(2):e17-21. doi: 10.1016/j.cllc.2015.12.001. Epub 2015 Dec 18.

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.肺腺癌伴 BRAF G469L 突变，对 vemurafenib 耐药。

Lung Cancer. 2013 Nov;82(2):365-7. doi: 10.1016/j.lungcan.2013.08.012. Epub 2013 Aug 19.

BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.BRAF V600E突变型肺腺癌伴脑转移，对维莫非尼治疗有反应。

Lung Cancer. 2014 Aug;85(2):326-30. doi: 10.1016/j.lungcan.2014.05.009. Epub 2014 May 21.

Response to dabrafenib after progression on vemurafenib in a patient with advanced BRAF V600E-mutant bronchial adenocarcinoma.一名晚期BRAF V600E突变型支气管腺癌患者在维莫非尼治疗进展后对达拉非尼的反应。

Lung Cancer. 2015 Jan;87(1):85-7. doi: 10.1016/j.lungcan.2014.11.008. Epub 2014 Nov 18.

Dramatic response induced by vemurafenib in a BRAF V600E-mutated lung adenocarcinoma.维莫非尼对BRAF V600E突变型肺腺癌引起的显著反应。

J Clin Oncol. 2013 Jul 10;31(20):e341-4. doi: 10.1200/JCO.2012.47.6143. Epub 2013 Jun 3.

BRAFV600 mutant non-small-cell lung cancer resistant to Vemurafenib.对维莫非尼耐药的BRAFV600突变型非小细胞肺癌

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3294-8. eCollection 2015.

Rapidly metastasizing malignant melanoma characterized by a rare BRAF mutation not responding to vemurafenib.以罕见的BRAF突变且对维莫非尼无反应为特征的快速转移恶性黑色素瘤。

J Dtsch Dermatol Ges. 2014 Feb;12(2):151-4. doi: 10.1111/ddg.12231. Epub 2013 Nov 18.

Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.携带BRAF V600E突变的严重皮肤朗格汉斯细胞组织细胞增多症患者对维莫非尼有显著反应。

J Am Acad Dermatol. 2014 Sep;71(3):e97-9. doi: 10.1016/j.jaad.2014.03.038.

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.维莫非尼治疗肺腺癌继发环状肉芽肿

J Drugs Dermatol. 2017 Oct 1;16(10):1050-1052.

引用本文的文献

Proceedings from the First Onco Summit: LATAM Chapter, 19-20 May 2023, Rio de Janeiro, Brazil.第一届肿瘤学峰会会议记录：拉丁美洲分会，2023年5月19日至20日，巴西里约热内卢

Cancers (Basel). 2024 Sep 3;16(17):3063. doi: 10.3390/cancers16173063.

RAF and MEK Inhibitors in Non-Small Cell Lung Cancer.RAF 和 MEK 抑制剂在非小细胞肺癌中的应用。

Int J Mol Sci. 2024 Apr 24;25(9):4633. doi: 10.3390/ijms25094633.

Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors.丝氨酸/苏氨酸激酶BRAF的突变：实体瘤中的致癌驱动因素

Cancers (Basel). 2024 Mar 20;16(6):1215. doi: 10.3390/cancers16061215.

BRAF Inhibitors in Non-Small Cell Lung Cancer.BRAF抑制剂在非小细胞肺癌中的应用

Cancers (Basel). 2022 Oct 5;14(19):4863. doi: 10.3390/cancers14194863.

BRAF: A Two-Faced Janus.BRAF：两面神。

Cells. 2020 Nov 27;9(12):2549. doi: 10.3390/cells9122549.

A Rare Case of Non-Small Cell Lung Cancer with BRAF V600E Gene: Case Report and Literature Review.一例罕见的伴有BRAF V600E基因的非小细胞肺癌：病例报告及文献综述

Cureus. 2020 Feb 20;12(2):e7055. doi: 10.7759/cureus.7055.

Patients with non-small-cell lung cancer harbouring a mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14.携带某种突变的非小细胞肺癌患者：一项在现实环境中探索临床特征、治疗及结局的多中心研究：EXPLORE GFPC 02-14

Curr Oncol. 2018 Oct;25(5):e398-e402. doi: 10.3747/co.25.3945. Epub 2018 Oct 31.

Identification of a Novel BRAF Thr599dup Mutation in Lung Adenocarcinoma.肺腺癌中一种新型BRAF Thr599dup突变的鉴定

Open Med (Wars). 2018 Jul 10;13:278-280. doi: 10.1515/med-2018-0042. eCollection 2018.

Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.开发超短 PCR 检测法以揭示泰国结直肠癌组织中的 BRAF V600 突变状态。

PLoS One. 2018 Jun 7;13(6):e0198795. doi: 10.1371/journal.pone.0198795. eCollection 2018.

A Case Series of Two Patients Presenting With Pericardial Effusion as First Manifestation of Non-Small Cell Lung Cancer With Mutation and Expression Of PD-L1.两例以心包积液为非小细胞肺癌首发表现且伴有PD-L1突变与表达的病例系列

World J Oncol. 2018 Apr;9(2):56-61. doi: 10.14740/wjon1092w. Epub 2018 May 1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验